Clinical Trial Update: Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of low-dose radiation with neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Snippet

Sponsor: Sichuan University | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING